Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Correction for Skrabal et al., Am J Health Syst Pharm 60 (6) 578-581.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skrabal, M. Z.
Right arrow Articles by Monaghan, M. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Skrabal, M. Z.
Right arrow Articles by Monaghan, M. S.

Two cases of rhab domyolysis associated with high-dose simvastatin

Maryann Z. Skrabal , Julie A. Stading , Carrie A. Cannella , and Michael S. Monaghan


(March 15, 2003, Grand Rounds). On page 579, the first sentence of the Discussion should read, ``The renal consultation recommended stopping the patient's fexofenadine, temazepam, simvastatin, and nefazodone because all of these agents belong to therapeutic classes that have been associated with rhabdomyolysis.''

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society of Health-System Pharmacists.